A detailed history of D.A. Davidson & Co. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, D.A. Davidson & Co. holds 81,254 shares of TEVA stock, worth $1.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
81,254
Previous 70,623 15.05%
Holding current value
$1.39 Million
Previous $996,000 32.53%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$12.78 - $17.4 $135,864 - $184,979
10,631 Added 15.05%
81,254 $1.32 Million
Q1 2024

May 13, 2024

BUY
$10.67 - $14.43 $523,406 - $707,849
49,054 Added 227.43%
70,623 $996,000
Q4 2023

Feb 09, 2024

SELL
$8.12 - $10.63 $3,207 - $4,198
-395 Reduced 1.8%
21,569 $225,000
Q1 2023

Apr 25, 2023

SELL
$8.36 - $11.37 $4,180 - $5,685
-500 Reduced 2.23%
21,964 $194,000
Q4 2022

Feb 03, 2023

SELL
$7.95 - $9.48 $3,180 - $3,792
-400 Reduced 1.75%
22,464 $204,000
Q3 2022

Nov 07, 2022

BUY
$6.86 - $11.95 $17,554 - $30,580
2,559 Added 12.6%
22,864 $185,000
Q2 2022

Jul 28, 2022

SELL
$7.38 - $10.4 $11,033 - $15,548
-1,495 Reduced 6.86%
20,305 $153,000
Q1 2022

May 12, 2022

BUY
$7.33 - $9.39 $1,370 - $1,755
187 Added 0.87%
21,800 $205,000
Q4 2021

Jan 31, 2022

SELL
$7.9 - $10.19 $16,661 - $21,490
-2,109 Reduced 8.89%
21,613 $173,000
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $13,408 - $16,288
-1,600 Reduced 6.32%
23,722 $231,000
Q2 2021

Aug 10, 2021

SELL
$9.9 - $11.56 $13,820 - $16,137
-1,396 Reduced 5.22%
25,322 $251,000
Q1 2021

May 07, 2021

BUY
$10.34 - $12.81 $26,997 - $33,446
2,611 Added 10.83%
26,718 $308,000
Q4 2020

Feb 10, 2021

SELL
$8.61 - $11.04 $15,541 - $19,927
-1,805 Reduced 6.97%
24,107 $233,000
Q3 2020

Nov 02, 2020

SELL
$8.57 - $12.69 $9,315 - $13,794
-1,087 Reduced 4.03%
25,912 $233,000
Q2 2020

Aug 10, 2020

SELL
$8.12 - $13.12 $37,847 - $61,152
-4,661 Reduced 14.72%
26,999 $333,000
Q1 2020

May 05, 2020

SELL
$6.69 - $13.45 $2,575 - $5,178
-385 Reduced 1.2%
31,660 $284,000
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $8,169 - $13,410
1,251 Added 4.06%
32,045 $314,000
Q3 2019

Nov 05, 2019

SELL
$6.16 - $9.6 $14,476 - $22,560
-2,350 Reduced 7.09%
30,794 $212,000
Q2 2019

Aug 13, 2019

SELL
$8.12 - $15.72 $118,738 - $229,873
-14,623 Reduced 30.61%
33,144 $306,000
Q1 2019

May 13, 2019

SELL
$15.58 - $20.01 $46,708 - $59,989
-2,998 Reduced 5.91%
47,767 $747,000
Q4 2018

Jan 29, 2019

SELL
$14.59 - $23.84 $3,997 - $6,532
-274 Reduced 0.54%
50,765 $783,000
Q3 2018

Nov 13, 2018

BUY
$21.06 - $25.65 $32,516 - $39,603
1,544 Added 3.12%
51,039 $1.1 Million
Q2 2018

Aug 02, 2018

BUY
$16.77 - $24.71 $12,091 - $17,815
721 Added 1.48%
49,495 $1.2 Million
Q1 2018

May 04, 2018

SELL
$16.68 - $22.07 $84,484 - $111,784
-5,065 Reduced 9.41%
48,774 $834,000
Q4 2017

Feb 08, 2018

SELL
$11.23 - $19.1 $121,553 - $206,738
-10,824 Reduced 16.74%
53,839 $1.02 Million
Q3 2017

Nov 08, 2017

SELL
$15.41 - $32.17 $3.11 Million - $6.49 Million
-201,758 Reduced 75.73%
64,663 $1.14 Million
Q2 2017

Aug 11, 2017

BUY
N/A
266,421
266,421 $0

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track D.A. Davidson & Co. Portfolio

Follow D.A. Davidson & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.